Princess of Wales Undergoes Planned Abdominal Surgery
17 Jan 2024
WEDNESDAY, Jan. 17, 2024 -- Kate Middleton, the Princess of Wales, has undergone a planned abdominal surgery, Kensington Palace reported Wednesday.
As reported by the BBC, the surgery was successful and the 42-year-old princess will remain in the hospital for between 10 and 14 days.
No details were provided by the palace as to the reasons for the surgery.
"Her Royal Highness The Princess of Wales was admitted to The London Clinic yesterday for planned abdominal surgery," the palace statement read. "Based on the current medical advice, she is unlikely to return to public duties until after Easter."
The statement conveyed the princess' apology for postponing upcoming engagements. It went on to say that the princess is aware that the public will have some interest in her surgery, but hopes people "will understand her desire to maintain as much normality for her children as possible."
The surgery was carried out at The London Clinic, which calls itself the United Kingdom's largest private hospital.
SOURCE: BBC News
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.